Tratamento progressivo vs. início imediato de tratamento mais potente para pacientes com esclerose múltipla recorrente-remitente: dados de 2 estratégias nacionais diferentes.

Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies – JAMA Neurology (gratuito por tempo limitado)

Comentário no Twitter

Study suggests that escalation of #multiplesclerosis treatment was inferior to initial treatment with a more effective disease-modifying agent https://t.co/hkHsAXP5se

— JAMA Neurology (@JAMANeuro) August 16, 2021